Search For "expert committee"
NGT constitutes committee in plea challenging environmental clearance to h
Updated : 4 years, 1 month ago IST
New Delhi [India], January 22 (ANI): The National Green Tribunal (NGT) has constituted an independent Expert Committee comprising of multi-disciplinary authorities in an appeal moved against Environmental Clearance (EC) granted by the Ministry of Environment, Forest & Climate Change (MoE
Read More
SEC recommends regular market approval to Covaxin, Covishield for adults
Updated : 4 years, 1 month ago IST
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
Read More
Tableau couldn't make it to final list: Rajnath Singh writes to MK Stalin
Updated : 4 years, 1 month ago IST
New Delhi [India], January 18 (ANI): A day after Tamil Nadu Chief Minister MK Stalin wrote to Prime Minister Narendra Modi over Centre rejecting the state's tableau for the Republic Day Parade 2022, Union Defence Minister Rajnath Singh on Tuesday said that the tableau was considered in the f
Read More
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 1 month ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More
DCGI's SEC to review applications of Bharat Biotech, SII for full market a
Updated : 4 years, 1 month ago IST
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 2 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
SEC to take decision on antiviral Covid pill today
Updated : 4 years, 2 months ago IST
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
Read More
Can't prevent spread of Omicron: Member of Kerala COVID panel
Updated : 4 years, 2 months ago IST
Thiruvananthapuram (Kerala) [India], December 25 (ANI): The spread of the new Omicron variant of coronavirus cannot be stopped, adding that the cases of the new variant multiply every two days, says Dr TS Anish, member of COVID Expert Committee.
Read More
Dehradun-Delhi corridor: NGT appoints Expert Committee, directs steps for
Updated : 4 years, 3 months ago IST
New Delhi [India], December 13 (ANI): The National Green Tribunal (NGT) on Monday appointed an independent twelve-member Expert Committee in regards to diversion of forest land for non-forest purposes and cutting of trees for widening and elevating corridor construction for a part of NH 72A
Read More
No recommendations for COVID-19 booster dose by SEC: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Read More
Subject Expert Committee to meet tomorrow to discuss approval for Covishie
Updated : 4 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 booster dose, said sources on Thursday.
Read More